4
Changes in Ownership
MAXCYTE, INC. Filed Acc 0001209191-23-059910
Director sold 5,000 shares at $4.53 ($22,650)
- Director acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Johnston John Joseph Director | 2023-12-26 | Option exercise 10b5-1 | +5,000 | $2.14 | $10,710 | 125,583 | D: show line 1 in the form |
| Johnston John Joseph Director | 2023-12-26 | Sale 10b5-1 | −5,000 | $4.53 | $22,650 | 120,583 | D: show line 2 in the form |
| Open-market sales · 5,000 sh · avg $4.53 · $22,650 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Johnston John Joseph Director | 2023-12-26 | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 15,617 | D: show line 3 in the form |
Loading xslF345X05/doc4.xml…